Ab Index-Nr. 612-141-00-0

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
612-141-00-04,4'-methylenebis(2-ethylaniline);
4,4'-methylenebis(2-ethylbenzeneamine)
243-420-119900-65-3Carc. 2
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H302
H410
   
612-142-00-6biphenyl-2-ylamine201-990-990-41-5Carc. 2
Acute Tox. 4 (*)
Aquatic Chronic 3
H351
H302
H412
GHS08
GHS07
Wng
H351
H302
H412
   
612-143-00-1N5,N5-diethyltoluene-2,5-
diamine monohydrochloride;
4-diethylamino-2-methylaniline monohydrochloride
218-130-32051-79-8Acute Tox. 3 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H319
H317
H400
H410
GHS06
GHS09
Dgr
H301
H319
H317
H410
   
612-144-00-7flumetralin (ISO);
N-(2-chloro-6-fluorobenzyl)-
N-ethyl-α, α,α-tri-
fluoro-2,6-dinitro-p-toluidine
62924-70-3Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H317
H400
H410
GHS07
GHS09
Wng
H319
H315
H317
H410
   
612-145-00-2o-phenylenediamine202-430-695-54-5Carc. 2
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H341
H301
H332
H312
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H341
H301
H332
H312
H319
H317
H410
   
612-146-00-8o-phenylenediamine dihydrochloride210-418-7615-28-1Carc. 2
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H341
H301
H332
H312
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H341
H301
H332
H312
H319
H317
H410
   
612-147-00-3m-phenylenediamine203-584-7108-45-2Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H331
H311
H301
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H331
H311
H301
H319
H317
H410
   
612-148-00-9m-phenylenediamine dihydrochloride208-790-0541-69-5Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H341
H331
H311
H301
H319
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H341
H331
H311
H301
H319
H317
H410
   
612-149-00-41,3-diphenylguanidine203-002-1102-06-7Repr. 2
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H361f
(*)(*)(*)
H302
H319
H335
H315
H411
GHS08
GHS07
GHS09
Wng
H361f
(*)(*)(*)
H302
H319
H335
H315
H411
   
bis 30.11.2018:
612-150-00-X
spiroxamine (ISO);
8-tert-butyl-1,4-dioxaspi-
ro[4.5]decan-2-ylme-
thyl(ethyl)(propyl)amine
118134-30-8Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H315
H317
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H315
H317
H410
H350
   
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
612-150-00-X
Spiroxamin (ISO);
8-tert-Butyl-1,4-dioxa-
spiro[4.5]dec-2-ylmethyl-
ethylpropylamin
118134-30-8Repr. 2
Acute Tox. 4
Acute Tox. 4
Acute Tox. 4
STOT RE 2
 
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d
H332
H312
H302
H373 (Augen)
H315
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361d
H332
H312
H302
H373 (Augen)
H315
H317
H410
 M = 100
M = 100
 
612-151-00-5methyl-phenylene diamine;
diaminotoluene;
[technical product – reaction mass of
4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine
(EC No 212-513-9)]
Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H350
H341
H361f ***
H301
H312
H373 **
H319
H317
H411
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f ***
H301
H312
H373 **
H319
H317
H411
   
612-152-00-0N,N-diethyl-N',N'-dimethyl-
propan-1,3-diyldiamine
406-610-762478-82-4Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1A
Aquatic Chronic 3
H226
H332
H302
H373 (*)(*)
H314
H412
GHS02
GHS08
GHS05
GHS07
Dgr
H226
H332
H302
H373 (*)(*)
H314
H412
   
612-153-00-64-[N-ethyl-N-(2-hydroxy-
ethyl)amino]-1-(2-hydroxy-
ethyl)amino-2-nitrobenzene, monohydrochloride
407-020-2132885-85-9Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
   
612-154-00-16'-(isobutylethylamino)-3'-
methyl-2'-pheny-
lamino-spiro[isobenzo-2-
oxofuran-7,9'-
[9H]-xanthene]
410-890-695235-29-3Aquatic Chronic 4H413H413   
612-155-00-72'-anilino-6'-((3-ethoxypro-
pyl)ethylamino)-
3'-methylspiro(isobenzo-3-
oxofuran)-1-(1H)-9'-xanthene
411-730-893071-94-4Aquatic Chronic 4H413H413   
612-156-00-2reaction mass of: trihexadecylmethylammo-
nium chloride;
dihexadecyldimethylam-
monium chloride
405-620-9Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
   
612-157-00-8(Z)-1-benzo[b]thien-2-yletha-
none oxime
hydrochloride
410-780-8Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H373 (*)(*)
H318
H317
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 (*)(*)
H318
H317
H411
   
612-158-00-3reaction mass of:
bis(5-dodecyl-2-hydroxy-
benzald-oximate) copper (II) C12-alkyl group is branched;
4-dodecylsalicylaldoxime
410-820-4Aquatic Chronic 4H413H413   
612-159-00-9Reaction products of:
trimethylhexamethy-
lene diamine (a mixture of 2,2,4-trimethyl-1,6-hexa-
nediamine and 2,4,4-tri-
methyl-1,6-hexanediamine, EINECS listed), Epoxide 8
(mono[(C10-C16-alkyl-
oxy)methyl]oxirane
derivatives) and p-toluene-sulfonic acid
410-880-1Acute Tox. 4 (*)
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H410
   
612-160-00-4p-toluidine;
4-aminotoluene; [1]
toluidinium chloride; [2]
toluidine sulphate (1:1) [3]
203-403-1 [1]
208-740-8 [2]
208-741-3 [3]
106-49-0 [1]
540-23-8 [2]
540-25-0 [3]
Carc. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H351
H331
H311
H301
H319
H317
H400
GHS06
GHS08
GHS09
Dgr
H351
H331
H311
H301
H319
H317
H400
   
612-161-00-X2,6-xylidine;
2,6-dimethylaniline
201-758-787-62-7Carc. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H351
H332
H312
H302
H335
H315
H411
GHS08
GHS07
GHS09
Wng
H351
H332
H312
H302
H335
H315
H411
   
612-162-00-5dimethyldioctadecylam-
monium chloride;
DODMAC
203-508-2107-64-2Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
   
612-163-00-0metalaxyl-M (ISO);
mefenoxam;
(R)-2-[(2,6-dimethylphenyl)-
methoxyacetyla-
mino]propionic acid methyl ester
70630-17-0Acute Tox. 4 (*)
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
   
612-164-00-62-butyl-2-ethyl-1,5-diamino-
pentane
412-700-7137605-95-9Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H312
H302
H373 (*)(*)
H314
H317
H412
GHS08
GHS05
GHS07
Dgr
H312
H302
H373 (*)(*)
H314
H317
H412
   
612-165-00-1N,N'-diphenyl-N,N'-bis(3-
methylphenyl)-(1,1'-di-
phenyl)-4,4'-diamine
413-810-865181-78-4Aquatic Chronic 2H411GHS09H411   
612-166-00-7reaction mass of:
cis-(5-ammonium-1,3,3-
trimethyl)-cyclohexane-
methylammonium
phosphate (1:1);
trans-(5-ammonium-1,3,3-
trimethyl)-cyclohexane-
methylammonium phosphate (1:1)
411-830-1114765-88-7Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
   
612-167-00-25-acetyl-3-amino-10,11-
dihydro-5H-dibenz
[b,f]azepine-hydrochloride
410-490-1Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H373 (*)(*)
H318
H317
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 (*)(*)
H318
H317
H411
   
612-168-00-83,5-dichloro-2,6-difluoro-
pyrdine-4-amine
220-630-12840-00-8Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Chronic 2
H312
H302
H411
GHS07
GHS09
Wng
H312
H302
H411
   
612-169-00-3bis(N-methyl-N-phenyl-
hydrazine)sulfate
423-170-1618-26-8Flam. Liq. 2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H225
H372 **
H302
H318
H317
H400
H410
GHS02
GHS05
GHS08
GHS07
GHS09
Dgr
H225
H372 **
H302
H318
H317
H410
   
612-170-00-94-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime405-260-2Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
   
612-171-00-4N,N,N',N'-tetraglycidyl-4,4'-
diamino-3,3'-diethyldiphenyl-
methane
410-060-3130728-76-6Muta. 2
Skin Sens. 1
Aquatic Chronic 2
H341
H317
H411
GHS08
GHS09
Wng
H341
H317
H411
   
612-172-00-X4,4'-methylenebis(N,N'-
dimethylcyclohexanamine
412-840-913474-64-1Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1A
Aquatic Chronic 3
H302
H373 (*)(*)
H314
H412
GHS08
GHS05
GHS07
Dgr
H302
H373 (*)(*)
H314
H412
   
612-173-00-5lithium 1-amino-4-(4-tert-
butylanilino)anth-
raquinone-2-sulfonate
411-140-0125328-86-1Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
   
612-174-00-04,4-dimethoxybutylamine407-690-619060-15-2Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3
H302
H314
H317
H412
GHS05
GHS07
Dgr
H302
H314
H317
H412
   
612-175-00-62-(O-aminooxy)ethylamine dihydrochloride412-310-737866-45-8Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
612-176-00-1polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-
dimethyl-1,3-propanediamine
410-570-6143747-73-3Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
612-177-00-72-naphthylamino-6-
sulfomethylamide
412-120-4104295-55-8STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 2
H373 (*)(*)
H317
H411
GHS08
GHS09
Wng
H373 (*)(*)
H317
H411
   
612-178-00-21,4,7,10-tetraazacyclodo-
decane disulfate
412-080-8112193-77-8Acute Tox. 4 (*)
STOT SE 3
Eye Dam. 1
Aquatic Chronic 3
H302
H335
H318
H412
GHS05
GHS07
Dgr
H302
H335
H318
H412
   
612-179-00-81-(2-propenyl)pyridinium chloride412-740-525965-81-5Acute Tox. 4 (*)
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
   
612-180-00-33-aminobenzylamine412-230-24403-70-7Acute Tox. 4 (*)
Skin Corr. 1B
Aquatic Chronic 2
H302
H314
H411
GHS05
GHS07
GHS09
Dgr
H302
H314
H411
   
612-181-00-92-phenylthioaniline413-030-81134-94-7Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
612-182-00-41-ethyl-1-methylmorpholinium bromide418-210-165756-41-4Muta. 2H341GHS08
Wng
H341   
612-183-00-X1-ethyl-1-methylpyrrolidinium bromide418-200-569227-51-6Muta. 2H341GHS08
Wng
H341   
612-184-00-56'-(dibutylamino)-3'-methyl-2'-
(phenylamino)spiro[isobenzo-
furan-1(3H),9-(9H)-
xanthen]-3-one
403-830-589331-94-2Aquatic Chronic 3H412H412   
612-185-00-01-[3-[4-((heptadecafluorono-
nyl)oxy)-benzamido]propyl]-
N,N,N-trimethylammonium
iodide
407-400-859493-72-0Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
   
612-186-00-6bis(N-(7-hydroxy-8-methyl-5-
phenylphena-zin-3-ylidene)di-
methylammonium) sulfate
406-770-8149057-64-7STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 (*)(*)
H318
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H373 (*)(*)
H318
H317
H410
   
612-187-00-12,3,4-trifluoroaniline407-170-93862-73-5Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H312
H302
H373 (*)(*)
H315
H318
H411
GHS08
GHS05
GHS07
GHS09
Dgr
H312
H302
H373 (*)(*)
H315
H318
H411
   
612-188-00-74,4'-(9H-fluoren-9-ylidene)bis(2-
chloroaniline)
407-560-9107934-68-9Aquatic Chronic 2H411GHS09H411   
612-189-00-24-amino-2-(aminomethyl)phe-
nol dihydrochloride
412-510-4135043-64-0Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
   
612-190-00-84,4'-methylenebis(2-isopropyl-
6-methylaniline)
415-150-616298-38-7STOT RE 2 (*)
Aquatic Chronic 2
H373 (*)(*)
H411
GHS08
GHS09
Wng
H373 (*)(*)
H411
   
612-191-00-3polymer of allylamine hydrochloride415-050-271550-12-4Acute Tox. 4 (*)
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
   
612-192-00-92-isopropyl-4-(N-methyl)ami-
nomethylthiazole
414-800-6154212-60-9Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 2
H312
H302
H315
H318
H411
GHS05
GHS07
GHS09
Dgr
H312
H302
H315
H318
H411
   
612-193-00-43-methylaminomethyl-
phenylamine
414-570-718759-96-1Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H312
H302
H314
H317
H410
   
612-194-00-X2-hydroxy-3-[(2-hydroxyethyl)-
[2-(1-oxotetradecyl)ami-
no]ethyl]amino]-N,N,N-trime-
thyl-1-propanammonium chloride
414-670-0141890-30-4Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
   
612-195-00-5bis[tributyl 4-(methylbenzyl)am-
monium]1,5-naphthalene-
disulfonate
415-210-1160236-81-7Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H332
H302
H318
H410
   
612-196-00-04-chloro-o-toluidine; [1]
4-chloro-o-toluidine hydrochloride [2]
202-441-6 [1]
221-627-8 [2]
95-69-2 [1]
3165-93-3 [2]
Carc. 1B
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H331
H311
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H341
H331
H311
H301
H410
   
612-197-00-62,4,5-trimethylaniline; [1]
2,4,5-trimethylaniline hydrochloride [2]
205-282-0 [1]
[2]
137-17-7 [1]
21436-97-5 [2]
Carc. 1B
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Chronic 2
H350
H331
H311
H301
H411
GHS06
GHS08
GHS09
Dgr
H350
H331
H311
H301
H411
   
612-198-00-14,4'-thiodianiline and its salts205-370-9139-65-1Carc. 1B
Acute Tox. 4 (*)
Aquatic Chronic 2
H350
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H302
H411
   
612-199-00-74,4'-oxydianiline and its salts;
p-aminophenyl ether
202-977-0101-80-4Carc. 1B
Muta. 1B
Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Chronic 2
H350
H340
H361f
(*)(*)(*)
H331
H311
H301
H411
GHS06
GHS08
GHS09
Dgr
H350
H340
H361f
(*)(*)(*)
H331
H311
H301
H411
   
612-200-00-02,4-diaminoanisole; 4-methoxy-
m-phenylenediamine; [1]
2,4-diaminoanisole sulphate [2]
210-406-1 [1]
254-323-9 [2]
615-05-4 [1]
39156-41-7 [2]
Carc. 1B
Muta. 2
Acute Tox. 4 (*)
Aquatic Chronic 2
H350
H341
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H341
H302
H411
   
612-201-00-6N,N,N',N'-tetramethyl-4,4'-
methylendianiline
202-959-2101-61-1Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
   
612-202-00-13,4-dichloroaniline202-448-495-76-1Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H318
H317
H400
H410
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H318
H317
H410
   
612-203-00-7C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride
(chain < C8: < 3 %,
chain = C8: 15 %-70 %,
chain = C10: 30 %-85 %,
chain > C10: < 3 %)
417-360-3Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
H312
H302
H315
GHS07
Wng
H312
H302
H315
   
612-204-00-2C.I. Basic Violet 3;
4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-
2,5-dien-1-ylidene]dimethy-
lammonium chloride
208-953-6548-62-9Carc. 2
Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H318
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H351
H302
H318
H410
   
612-205-00-8C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no. 202-027-5)208-953-6548-62-9Carc. 1B
Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H302
H318
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H350
H302
H318
H410
   
612-206-00-3famoxadone (ISO);
3-anilino-5-methyl-5-
(4-phenoxyphenyl)-1,3-
oxazolidine-2,4-dione
131807-57-3STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H373 (*)(*)
H400
H410
GHS08
GHS09
Wng
H373 (*)(*)
H410
   
612-207-00-94-ethoxyaniline;
p-phenetidine
205-855-5156-43-4Muta. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1
H341
H332
H312
H302
H319
H317
GHS08
GHS07
Wng
H341
H332
H312
H302
H319
H317
   
612-208-00-4N-methylbenzene-1,2-diam-
monium hydrogen phosphate
424-460-0Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
   
612-209-00-X6-methoxy-m-toluidine;
p-cresidine
204-419-1120-71-8Carc. 1B
Acute Tox. 4 (*)
H350
H302
GHS08
GHS07
Dgr
H350
H302
   
612-210-00-55-nitro-o-toluidine; [1]
5-nitro-o-toluidine hydrochloride [2]
202-765-8 [1]
256-960-8 [2]
99-55-8 [1]
51085-52-0 [2]
Carc. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Chronic 3
H351
H331
H311
H301
H412
GHS06
GHS08
Dgr
H351
H331
H311
H301
H412
   
612-211-00-0N-[(benzotriazole-1-yl)me-
thyl)]-4-carboxybenzene-
sulfonamide
416-470-9170292-97-4Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
   
612-212-00-62,6-dichloro-4-trifluoro-
methylaniline
416-430-024279-39-8Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H315
H317
H400
H410
GHS07
GHS09
Wng
H332
H302
H315
H317
H410
   
612-213-00-1isobutylidene-(2-(2-isopropyl-
4,4-dimethyloxazolidine-
3-yl)-1,1-dimethylethyl)amine
419-850-2148348-13-4Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412
   
612-214-00-74-(2,2-diphenylethenyl)-N,N-
di-phenylbenzenamine
421-390-289114-90-9Aquatic Chronic 4H413H413   
612-215-00-23-chloro-2-(isopropylthio)ani-
line
421-700-6179104-32-6Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
612-216-00-81-amino-1-cyanamino-2,2-
dicyanoethylene, sodium salt
425-870-219450-38-5Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
612-217-00-31-methoxy-2-propylamine422-550-437143-54-7Flam. Liq. 2
Skin Corr. 1B
Acute Tox. 4 (*)
Aquatic Chronic 3
H225
H314
H302
H412
GHS02
GHS05
GHS07
Dgr
H225
H314
H302
H412
   
612-219-00-4(2-hydroxy-3-(3,4-dimethyl-9-
oxo-10-thiaanthracen-2-
yloxy)propyl)trimethylam-
monium chloride
402-200-7Aquatic Chronic 3H412H412   
612-220-00-XN-nitro-N-(3-methyl-3,6-
dihydro-2H-1,3,5-oxadiazin-
4-yl)amine
431-060-1153719-38-1Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
   
612-221-00-52-amino-4-(trifluoro-
methyl)benzenethiol hydro-
chloride
429-560-84274-38-8Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
H314
H332
H312
H302
H373 **
H317
H400
GHS05
GHS08
GHS07
GHS09
Dgr
H314
H332
H312
H302
H373 **
H317
H400
   
612-222-00-0cis-1-(3-(4-fluorophenoxy)pro-
pyl)-3-methoxy-4-piperidin-
amine
425-080-8104860-26-6Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373 **
H318
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H312
H302
H373 **
H318
H410
   
612-223-00-6N-benzyl-N-ethyl-(4-(5-nitro-
benzo[c]isothiazol-3-
ylazo)phenyl)amine
425-300-2186450-73-7Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
612-224-00-1N2,N4,N6-tris{4-[(1,4-
dimethylpentyl)amino]phe-
nyl}-1,3,5-triazine-2,4,6-triamine
426-150-0121246-28-4Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
612-225-00-71,4,7,10-tetraazacyclodo-
decane
425-450-9294-90-6Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H314
H312
H302
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H312
H302
H410
   
612-226-00-23-(2´-phenoxyethoxy)pro-
pylamine
427-870-86903-18-0Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3
H302
H315
H318
H412
GHS05
GHS07
Dgr
H302
H315
H318
H412
   
612-227-00-8benzyl-N-(2-(2-methoxy-
phenoxy)ethyl)amine hydro-
chloride
428-290-8120606-08-8Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H318
H410
   
612-228-00-3reaction mass of: N-(3-
(trimethoxysilyl)propyl)ethylene-
diamine;
N-benzyl-N-(3-(trimethoxy-
silyl)propyl)ethylene-
diamine;
N-benzyl-N´-[3-(trimethoxy-
silyl)propyl]ethylene-
diamine;
N,N´-bis-benzyl-N´-[3-
(trimethoxysilyl)propyl]ethy-
lenediamine;
N,N,N´-tris-benzyl-N´-[3-
(trimethoxysilyl)propyl]ethy-
lenediamine;
N,N-bis-benzyl-N´-[3-
(trimethoxysilyl)propyl]ethy-
lenediamine
414-340-6Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H226
H332
H312
H302
H371
H318
H317
H412
GHS02
GHS05
GHS08
GHS07
Dgr
H226
H332
H312
H302
H371
H318
H317
H412
   
612-229-00-9mepanipyrim;
4-methyl-N-phenyl-6-(1-
propynyl)-2-pyrimidinamine
110235-47-7Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
   
612-230-00-4N,N-bis(cocoyl-2-oxypropyl)-
N,N-dibutylammonium bromide
431-530-4Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
   
612-231-00-X3-((C12-18)-acylamino)-N-(2-((2-
hydroxyethyl)amino)-2-
oxoethyl)-N,N-dimethyl-1-
propanaminium chloride
427-370-1164288-56-6Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
   
612-232-00-5reaction mass of:
triisopropanola-
mine salt of 1-amino-4-(3-
propionamidoanilino)anthra-
quinone-2-sulfonic acid;
triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-
hydroxyethylaminosulfonyl)
anilino]anthraquinone-2-sulfonic
acid
430-410-9186148-38-9Aquatic Chronic 3H412H412   
612-237-00-2hydroxylammonium
hydrogensulfate;
hydroxylamine sulfate (1:1); [1]
hydroxylamine phosphate; [2]
hydroxylamine dihydrogen-
phosphate; [3]
hydroxylamine
4-methylbenzenesulfonate [4]
233-154-4 [1]
244-077-0 [2]
242-818-2 [3]
258-872-5 [4]
10046-00-1 [1]
20845-01-6 [2]
19098-16-9 [3]
53933-48-5 [4]
Expl. 1.1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H201
H351
H312
H302
H373 **
H319
H315
H317
H400
GHS01
GHS08
GHS07
GHS09
Dgr
H201
H351
H312
H302
H373 **
H319
H315
H317
H400
  T
612-238-00-8(3-chloro-2-hydroxypropyl) trimethylammonium chloride ... %222-048-33327-22-8Carc. 2
Aquatic Chronic 3
H351
H412
GHS08
Wng
H351
H412
  B
612-239-00-3biphenyl-3,3´,4,4´-tetrayltetraamine;
diaminobenzidine
202-110-691-95-2Carc. 1B
Muta. 2
H350
H341
GHS08
Dgr
H350
H341
   
612-240-00-9pyrimethanil (ISO);
N-(4,6-dimethylpyrimidin-2-yl)
aniline
53112-28-0Aquatic Chronic 2H411GHS09H411   
612-241-00-4piperazine hydrochloride; [1]
piperazine dihydrochloride; [2]
piperazine phosphate [3]
228-042-7 [1]
205-551-2 [2]
217-775-8 [3]
6094-40-2 [1]
142-64-3 [2]
1951-97-9 [3]
Repr. 2
Eye Irrit. 2
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H361fd
H319
H315
H334
H317
H412
GHS08
Dgr
H361fd
H319
H315
H334
H317
H412
   
612-242-00-Xcyprodinil (ISO);
4-cyclopropyl-6-methyl-N-
phenylpyrimidin-2-amine
121552-61-2Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
 M = 10 
612-243-00-5(1S-cis)-4-(3,4-dichlorophenyl)-
1,2,3,4-tetrahydro-N-methyl-1-
naphthalenamine 2-hydroxy-2-
phenylacetate
420-560-379617-97-3Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
 M = 10 
612-244-00-03-(piperazin-1-yl)-
benzo[d]isothiazole hydrochloride
421-310-687691-88-1Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f ***
H302
H319
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f ***
H302
H319
H317
H410
   
612-245-00-62-ethylphenylhydrazine
hydrochloride
421-460-219398-06-2Carc. 2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H372 **
H302
H318
H317
H400
H410
GHS05
GHS08
GHS07
GHS09
Dgr
H351
H372 **
H302
H318
H317
H410
 M = 10 
612-246-00-1(2-chloroethyl)(3-
hydroxypropyl)ammonium chloride
429-740-640722-80-3Carc. 1B
Muta. 1B
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3
H350
H340
H373 **
H317
H412
GHS08
GHS07
Dgr
H350
H340
H373 **
H317
H412
   
612-247-00-7N-[3-(1,1-dimethylethyl)-1H-
pyrazol-5-yl]-N´-hydroxy-4-
nitrobenzenecarboximidamide
423-530-8152828-23-4STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 3
H372 **
H302
H412
GHS08
GHS07
Dgr
H372 **
H302
H412
   
612-248-00-2reaction product of diphenylamine,
phenothiazine, and alkenes, branched (C8-10, C9-rich)
439-540-0Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H315
H317
H413
GHS07
Wng
H315
H317
H413
   
612-249-00-84-[(3-chlorophenyl)(1H-
imidazol-1-yl)methyl]-1,2-
benzenediamine dihydrochloride
425-030-5159939-85-2Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H361f ***
H302
H314
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H361f ***
H302
H314
H317
H411
   
612-250-00-3chloro-N,N-dimethylformiminium
chloride
425-970-63724-43-4Repr. 1B
Acute Tox. 4 *
Skin Corr. 1A
H360D*
H302
H314
GHS05
GHS08
GHS07
Dgr
H360D*
H302
H314
EUH014  
612-251-00-9cis-1-(3-chloroallyl)-3,5,7-
triaza-1-azoniaadamantane chloride
426-020-351229-78-8Flam. Sol. 2
Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H228
H361d ***
H302
H315
H317
H411
GHS02
GHS08
GHS07
GHS09
Wng
H228
H361d ***
H302
H315
H317
H411
   
612-252-00-4imidacloprid (ISO);
1-(6-chloropyridin-3-ylmethyl)-N-
nitroimidazolidin-2-ylidenamine
428-040-8138261-41-3Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
612-253-00-X7-methoxy-6-(3-morpholin-4-yl-
propoxy)-3H-quinazolin-4-one;
[containing < 0,5 % formamide
(EC No 200-842-0)]
429-400-7199327-61-2Aquatic Chronic 3H412H412   
612-253-01-77-methoxy-6-(3-morpholin-4-yl-
propoxy)-3H-quinazolin-4-one;
[containing ≥ 0,5 % formamide
(EC No 200-842-0)]
429-400-7199327-61-2Repr. 1B
Aquatic Chronic 3
H360D ***
H412
GHS08
Dgr
H360D ***
H412
   
612-254-00-5reaction products of diisopropanolamine with formaldehyde (1:4)432-440-8220444-73-5Carc. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H351
H302
H314
H317
H411
GHS05
GHS08
GHS07
GHS09
Dgr
H351
H302
H314
H317
H411
   
612-255-00-01-(3-methoxypropyl)-4-
piperidinamine
431-950-8179474-79-4Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3
H312
H302
H314
H412
GHS05
GHS07
Dgr
H312
H302
H314
H412
   
612-256-00-6benzyl(S)-2-[(2´-cyanobiphe-
nyl-4-ylmethyl)pentanoyl--
amino]-3-methylbutyrate
427-470-3137864-22-3Acute Tox. 4 *
Skin Sens. 1
H302
H317
GHS07
Wng
H302
H317
   
612-257-00-1tripropylammonium dihydrogen-
phosphate
433-700-335687-90-2Acute Tox. 4 *H302GHS07
Wng
H302   
612-259-00-2N-ethyl-3-trimethoxysilyl-2-
methylpropanamine
437-720-3227085-51-0Eye Dam. 1H318GHS05
Dgr
H318   
612-261-00-33,5-dichloro-2-fluoro-4-
(1,1,2,3,3,3-hexafluoro-
propoxy)aniline
441-190-9121451-05-6Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
 M = 10 
612-265-00-5bis(2-hydroxyethyl)-(2-
hydroxypropyl)ammonium acetate
444-360-0191617-13-7Aquatic Chronic 3H412H412   
612-266-00-03-chloro-4-(3-fluorobenzyl--
oxy)aniline
445-590-4202197-26-0Muta. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H341
H302
H373 **
H400
H410
GHS08
GHS07
GHS09
Wng
H341
H302
H373 **
H410
   
612-267-00-6bis(hydrogenated tallow
C16-18-alkyl)hydroxylamine
418-370-0Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
612-269-00-7reaction mass of: 1-[di(4-
octylphenyl)aminomethyl]-5-
methyl-1H-benzotriazole;
1-[di(4-octylphenyl)amino-
methyl]-4-methyl-1H-
benzotriazole;
reaction mass of:
N-[(5-methyl-1H-
benzotriazol-1-yl)methyl]-
4-octyl-N-(4-octylphenyl)aniline;
N-[(4-methyl-1H-benzotriazol-1-
yl)methyl]-4-octyl-N-(4-
octylphenyl)aniline
420-720-2Aquatic Chronic 4H413H413   
612-270-00-2(S)-azetidine-2-carboxylic acid
4-cyanobenzylamide hydrochloride
433-010-2Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
   
612-271-00-8reaction mass of: ethyl 2-((4-
(5,6-dichlorobenzothiazol-2-
ylazo)phenyl)ethylamino)ben-
zoate;
ethyl 2-((4-(6,7-dichlorobenzo-
thiazol-2-ylazo)phenyl)ethyl-
amino)benzoate
434-970-5160987-57-5Aquatic Chronic 4H413H413   
612-272-00-3ammonium (η-6-2-(2-(1,2-
dicarboxylatoethylamino)
ethylamino)butane-1,4-
dioato(4-))iron(3+) monohydrate
435-210-5Aquatic Chronic 2H411GHS09H411   
612-273-00-9alkyl(rapeseed oil), bis(2-
hydroxyethyl)ammonium fluoride
435-650-8Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H410
   
612-274-00-4(R,S)-1-[2-amino-1-(4-me-
thoxyphenyl)ethyl]cyclo-
hexanol acetate
445-750-3Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H318
H317
H412
GHS05
GHS07
Dgr
H302
H318
H317
H412
   
612-275-00-Xfatty acids, C18-unsatd., dimers, reaction products with 1-pipera-
zineethanamine and tall oil
447-880-6206565-89-1Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H315
H318
H317
H410
 M = 10 
612-276-00-51-amino-4-[(4-amino-2-
sulfofenyl)amino]-9,10-dihydro-
9,10-dioxo-2-anthracenesulfonic
acid, disodium salt, reaction products with 2-[[3-[(4,6-
dichloro-1,3,5-triazin-2-
yl)ethylamino]phenyl]sul-
fonyl]ethylhydrogen sulfate, sodium salts
451-430-4500717-36-2Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H317
H412
GHS05
GHS07
Dgr
H318
H317
H412
   
612-277-00-0reaction mass of: 4-amino-3-
(4-ethenesulfonyl-2-
sulfonatophenylazo)-5-
hydroxy-6-(5-{4-chloro-6-[4-(2-
sulfonatooxyethanesulfonyl)
phenylamino]-1,3,5-triazin-2-
ylamino}-2-sulfonatophenyl-
azo)naphthalene-2,7-
disulfonate potassium/sodium;
4-amino-5-hydroxy-6-(5-{4-
chloro-6-[4-(2-sulfonatooxy-
ethanesulfonyl)phenylamino]-
1,3,5-triazin-2-ylamino}-2-
sulfonatophenylazo)-3-
(2-sulfonato-4-(2-
sulfonatooxyethanesulfonyl)
phenylazo)naphthalene-2,7-
disulfonate potassium/sodium
451-440-9586372-44-3Eye Dam. 1H318GHS05
Dgr
H318   
612-278-00-6ethidium bromide;
3,8-diamino-1-ethyl-6-
phenylphenantridinium bromide
214-984-61239-45-8Muta. 2
Acute Tox. 2 *
Acute Tox. 4 *
H341
H330
H302
GHS06
GHS08
Dgr
H341
H330
H302
   
612-279-00-1(R,S)-2-amino-3,3-dimethyl-
butane amide
447-860-7144177-62-8Repr. 2
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H361f ***
H373 **
H319
H315
H317
GHS08
GHS07
Wng
H361f ***
H373 **
H319
H315
H317
   
612-280-00-73-amino-9-ethyl carbazole;
9-ethylcarbazol-3-ylamine
205-057-7132-32-1Carc. 1BH350GHS08
Dgr
H350   
612-281-00-2leucomalachite green;
N,N,N',N'-tetramethyl-4,4'- benzylidenedianiline
204-961-9129-73-7Carc. 2
Muta. 2
H351
H341
GHS08
Wng
H351
H341
   
612-282-00-8octadecylamine204-695-3124-30-1Asp. Tox. 1
STOT RE 2
 
 
 
 
 
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H304
H373
(Ma­gen-Darm-Trakt, Leber, Immun­sys­tem)
H315
H318
H400
H410
GHS05
GHS08
 
 
 
 
 
GHS09
Dgr
H304
H373
(Ma­gen-Darm-Trakt, Leber, Immun­sys­tem)
H315
H318
 
H410
 M = 10
M = 10
 
612-283-00-3(Z)-octadec-9-enylamine204-015-5112-90-3Acute Tox. 4
Asp Tox. 1
STOT SE 3
STOT RE 2
 
 
 
 
 
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H304
H335
H373
(Ma­gen-Darm-Trakt, Leber, Immun­sys­tem)
H314
H400
H410
GHS05
GHS07
GHS08
GHS09
 
 
 
 
 
Dgr
H302
H304
H335
H373
(Ma­gen-Darm-Trakt, Leber, Immun­sys­tem)
H314
 
H410
 M = 10
M = 10
 
612-284-00-9amines, hydrogenated tallow alkyl262-976-661788-45-2Asp Tox. 1
STOT RE 2
 
 
 
 
 
Skin Corr. 1B
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H304
H373
(Ma­gen-Darm-Trakt, Leber, Immun­sys­tem)
H315
H318
H400
H410
GHS08
GHS05
 
 
 
 
 
GHS09
Dgr
H304
H373
(Ma­gen-Darm-Trakt, Leber, Immun­sys­tem)
H315
H318
 
H410
 M = 10
M = 10
 
612-285-00-4amines, coco alkyl262-977-161788-46-3Acute Tox. 4
Asp Tox. 1
STOT SE 3
STOT RE 2
 
 
 
 
 
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H304
H335
H373
(Ma­gen-Darm-Trakt, Leber, Immun­sys­tem)
H314
H400
H410
GHS05
GHS07
GHS08
GHS09
 
 
 
 
 
Dgr
H302
H304
H335
H373
(Ma­gen-Darm-Trakt, Leber, Immun­sys­tem)
H314
 
H410
 M = 10
M = 10
 
612-286-00-Xamines, tallow alkyl263-125-161790-33-8Acute Tox. 4
Asp Tox. 1
STOT RE 2
 
 
 
 
 
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H302
H304
H373
(gastro-intestinal tract, liver, immune system)
H314
H400
H410
GHS05
GHS07
GHS08 
 
 
 
 
 
GHS09
Dgr
H302
H304
H373
(gastro-intestinal tract, liver, immune system)
H314
 
H410
 M = 10
M = 10
 
612-287-00-5fluazinam (ISO);
3-chloro-N-[3-chloro- 2,6-dinitro-
4-(trifluoromethyl)phenyl]-5-
(trifluoromethyl)pyridin-2-amine
79622-59-6Repr. 2
Acute Tox. 4
Eye Dam. 1
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic 1
H361d
H332
H318
H317
H400
H410
GHS08
GHS07
GHS05
GHS09
Dgr
H361d
H332
H318
H317
H410
 M = 10
M = 10
 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
612-288-00-0
Bupirimat (ISO);
5-Butyl-2-ethylamino-6-
methylpyrimidin-4-yl
dimethylsulfamat
255-391-241483-43-6Carc. 2
Skin Sens. 1B
Aquatic Chronic 1
H351
H317
H410
GHS08
GHS07
GHS09
Wng
H351
H317
H410
 M = 1 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
612-289-00-6
Triflumizol (ISO);
(1E)-N-[4-Chlor-2-(tri-
fluormethyl)phenyl]-1-
(1H-imidazol-1-yl)-2-
propoxyethanimin
68694-11-1Repr. 1B
Acute Tox. 4
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H360D
H302
H373 (Leber)
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H360D
H302
H373 (Leber)
H317
H400
H410
 M = 1
M = 1
 
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
612-290-00-1
Reaktionsprodukte von
Paraformaldehyd und
2-Hydroxypropylamin
(Verhältnis 3:2);
[aus 3,3'-Methylenbis[5-
methyloxazolidin
freigesetztes Formaldehyd]
[aus Oxazolidin freigesetztes
Formaldehyd];
[MBO]
Carc. 1B
Muta. 2
Acute Tox. 4
Acute Tox. 3
Acute Tox. 4
STOT RE 2
Skin Corr. 1B
Eye Dam. 1
Skin Sens. 1A
Aquatic Chronic 2
H350
H341
H332
H311
H302
H373
(Magen-
Darm-Trakt,
Atemwege)
H314
H318
H317
H411
GHS08
GHS06
GHS05
GHS09
Dgr
H350
H341
H332
H311
H302
H373
(Magen-
Darm-Trakt,
Atemwege)
H314
H317
H411
EUH071 8
9
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
612-291-00-7
Reaktionsprodukte von
Paraformaldehyd und
2-Hydroxypropylamin
(Verhältnis 1:1);
[aus α,α,α-Trimethyl-
1,3,5-triazin-1,3,5 (2H,4H,6H)-
triethanol freigesetztes
Formaldehyd];
[HPT]
Carc. 1B
Muta. 2
Acute Tox. 4
Acute Tox. 4
STOT RE 2
Skin Corr. 1C
Eye Dam. 1
Skin Sens. 1A
Aquatic Chronic 2
H350
H341
H332
H302
H373
(Magen-
Darm-Trakt,
Atemwege)
H314
H318
H317
H411
GHS08
GHS07
GHS05
GHS09
Dgr
H350
H341
H332
H302
H373
(Magen-
Darm-Trakt,
Atemwege)
H314
H317
H411
EUH071 8
9
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
612-292-00-2
Methylhydrazin200-471-460-34-4Carc. 1BH350GHS08
Dgr
H350   
613-001-00-1ethyleneimine;
aziridine
205-793-9151-56-4Flam. Liq. 2
Carc. 1B
Muta. 1B
Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
Skin Corr. 1B
Aquatic Chronic 2
H225
H350
H340
H330
H310
H300
H314
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H225
H350
H340
H330
H310
H300
H314
H411
  D